AstraZeneca Plans Advanced Manufacturing Center in Ireland

Published 10-4-2021

AstraZeneca is planning to construct a $360 million manufacturing center in the Blanchardstown region of Dublin. Located on the Alexion Campus in College Park, the next-generation facility will leverage advanced process technologies and digital innovation solutions to produce small-molecule APIs (active pharmaceutical ingredients). Significantly reducing commercialization lead times, the sustainably designed structure will integrate lean manufacturing practices to lower operating costs and reduce carbon emissions. The project represents AstraZeneca's first manufacturing plant in the Republic of Ireland.